Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adcal 1500mg chewable tablets
0905011D0BHAAAK
|
Adcal | Calcium carbonate | Nutrition and Blood | 33,888 |
|
Calcium carbonate 1.25g chewable tablets sugar free
0905011D0AAAJAJ
|
Calcium carbonate (Supplements) | Calcium carbonate | Nutrition and Blood | 24,836 |
|
Calcium carbonate 1.5g chewable tablets sugar free
0905011D0AAAKAK
|
Calcium carbonate (Supplements) | Calcium carbonate | Nutrition and Blood | 22,910 |
|
Calcichew 500mg chewable tablets
0905011D0BCAAAJ
|
Calcichew | Calcium carbonate | Nutrition and Blood | 21,589 |
|
Calcichew Forte chewable tablets
0905011D0BCABAG
|
Calcichew | Calcium carbonate | Nutrition and Blood | 5,212 |
|
Calcium carbonate 1.25g effervescent tablets sugar free
0905011D0AAADAD
|
Calcium carbonate (Supplements) | Calcium carbonate | Nutrition and Blood | 2,706 |
|
Calcium carbonate 500mg chewable tablets
0101021C0AAAFAF
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 2,601 |
|
Calcium carbonate 2.5g chewable tablets sugar free
0905011D0AAAGAG
|
Calcium carbonate (Supplements) | Calcium carbonate | Nutrition and Blood | 2,432 |
|
Cacit 500mg effervescent tablets
0905011D0BDAAAD
|
Cacit | Calcium carbonate | Nutrition and Blood | 915 |
|
Calcium carbonate 600mg/5ml oral suspension
0101021C0AACXCX
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 115 |
|
Calcium carbonate 500mg/5ml oral suspension
0101021C0AACYCY
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 113 |
|
Rennie Orange 500mg chewable tablets
0101021C0BIABAF
|
Rennie | Calcium carbonate | Gastro-Intestinal System | 100 |
|
Calcium carbonate 250mg dispersible tablets
0101021C0AACICI
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 79 |
|
Calcium carbonate 300mg tablets
0101021C0AAATAT
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 38 |
|
A1-Cal 500mg effervescent tablets
0905011D0BIACAD
|
A1-Cal | Calcium carbonate | Nutrition and Blood | 34 |
|
Calcium carbonate 800mg chewable tablets
0101021C0AABXBX
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 32 |
|
SunVit-Pro Calcium carbonate 1.25g chewable tablets
0905011D0BKAAAJ
|
SunVit-Pro Calcium carbonate | Calcium carbonate | Nutrition and Blood | 30 |
|
Calcium carbonate 1.25g tablets
0905011D0AAAEAE
|
Calcium carbonate (Supplements) | Calcium carbonate | Nutrition and Blood | 28 |
|
Calcium carbonate 625mg effervescent tablets sugar free
0905011D0AAANAN
|
Calcium carbonate (Supplements) | Calcium carbonate | Nutrition and Blood | 20 |
|
A1-Cal 500mg chewable tablets
0905011D0BIAAAJ
|
A1-Cal | Calcium carbonate | Nutrition and Blood | 11 |
|
Calcium carbonate 120mg/5ml oral suspension
0101021C0AACWCW
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 9 |
|
Calcium carbonate 250mg/5ml oral suspension
0101021C0AACECE
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 9 |
|
SunVit-Pro Calcium carbonate 1.5g chewable tablets
0905011D0BKABAK
|
SunVit-Pro Calcium carbonate | Calcium carbonate | Nutrition and Blood | 9 |
|
Calcium carbonate 250mg dispersible tablets sugar free
0905011D0AAAPAP
|
Calcium carbonate (Supplements) | Calcium carbonate | Nutrition and Blood | 8 |
|
Calcium carbonate 400mg capsules
0101021C0AABQBQ
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 5 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.